Smith & Nephew (SN) Trading Up 0% After Insider Buying Activity
Smith & Nephew plc (LON:SN) was up 0% during mid-day trading on Friday following insider buying activity. The stock traded as high as GBX 1,254.50 ($17.59) and last traded at GBX 1,227 ($17.20). Approximately 3,610,000 shares changed hands during mid-day trading, an increase of 31% from the average daily volume of 2,760,000 shares. The stock had previously closed at GBX 1,227 ($17.20).
Specifically, insider Angie Risley acquired 1,601 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was acquired at an average price of GBX 1,249 ($17.51) per share, with a total value of £19,996.49 ($28,037.70).
A number of equities analysts recently weighed in on SN shares. JPMorgan Chase & Co. upped their price target on Smith & Nephew from GBX 1,361 ($19.08) to GBX 1,382 ($19.38) and gave the stock a “neutral” rating in a report on Thursday, October 19th. Deutsche Bank upped their price target on Smith & Nephew from GBX 1,200 ($16.83) to GBX 1,315 ($18.44) and gave the stock a “hold” rating in a report on Monday, October 23rd. Jefferies Group reaffirmed a “buy” rating and issued a GBX 1,515 ($21.24) price target on shares of Smith & Nephew in a report on Monday, November 6th. Berenberg Bank reaffirmed a “hold” rating and issued a GBX 1,340 ($18.79) price target on shares of Smith & Nephew in a report on Friday, November 3rd. Finally, Credit Suisse Group upped their price target on Smith & Nephew from GBX 1,285 ($18.02) to GBX 1,290 ($18.09) and gave the stock a “neutral” rating in a report on Friday. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of GBX 1,322.50 ($18.54).
COPYRIGHT VIOLATION WARNING: “Smith & Nephew (SN) Trading Up 0% After Insider Buying Activity” was posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/smith-nephew-sn-trading-up-0-after-insider-buying-activity/1858331.html.
Smith & Nephew Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.